Success Story: EB-1A Approval for a Principal Research Scientist in the field of Biochemistry
Client’s Testimonial:
Thanks a lot. Congratulations to you also.
Definitely I recommend my friends and colleagues to go with you.
On September 23rd, 2013 we received another EB1-A (Alien of Extraordinary Ability) Approval for a Principal Research Scientist in the field of Biochemistry (Approval Notice)
General Field: Biochemistry
Position at the Time of Case Filing: Principal Research Scientist
National Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: September 23, 2013
Processing Time: 3 days (Premium Processing requested)
Case Summary:
The client in this case was a Principal Research Scientist from India in the field of biochemistry. His work had primarily focused on the synthesis of organic compounds for use in pharmaceuticals and other health care-related applications. His work had resulted in at least 25 peer-reviewed scientific articles and 6 conference proceedings. At the time that his case was filed, his publications had accumulated at least 379 citations, clearly demonstrating that he had influenced his field and garnered international acclaim. In addition, he had served as a peer reviewer for 3 journals related to the field of biochemistry. Of his accomplishments, one of his independent recommenders remarked, “In summary, [client] is an accomplished researcher and expert chemist with a strong background in organic, medicinal, and green chemistry. His expertise will continue to lead to major developments in these fields. He specializes in the novel synthesis of therapeutic agents and has a wide spectrum of state-of-the-art analytical techniques for the substantial benefit of the scientific community in the USA and around the world.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of biochemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 3 days.

